h-ser-asp-ala-ala-val-asp-thr-ser-ser-glu-ile-thr-thr-lys-asp-leu-lys-glu-lys-lys-glu-val-val-glu-glu-ala-glu-asn-oh
74221-77-5
|
2-[2-[[2-[[2-[(2-amino-3-methylbutanoyl)amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]propanoylamino]pentanedioic acid,azane
100930-17-4
|
h-his-his-gly-val-val-glu-val-asp-ala-ala-val-thr-pro-glu-glu-arg-his-leu-ser-lys-oh
158561-91-2
|
VAL-HIS-LEU-THR-PRO-VAL-GLU-LYS
62526-81-2
|
VAL-GLU-PRO-ILE-PRO-TYR
94773-24-7
|
Val-Val-Asp(OBzl)-OBzl
70853-23-5
|
Val-Val-Tyr-Pro-Asp-OH
193750-11-7
|
NFAT Inhibitor trifluoroacetate salt
249537-73-3
|
[D-Ala2] -Deltorphin II
122752-16-3
|
Ethyl 1-(piperazin-1-yl)cyclopropanecarboxylate hydrochloride
1629089-23-1
|
N-[3-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2-propenamide
1629585-55-2
|
7-Chloro-4,5-difluorobenzo[c][1,2]oxaborole-1,6(3H)-diol
1629141-02-1
|
1-(1-Phenylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole
1629171-81-8
|
[1-(oxan-3-yl)-1H-pyrazol-4-yl]boronic acid
1694659-43-2
|
5-bromo-2,2-dimethyl-1-(trifluoromethyl)-2,3-dihydro-1H-inden-1-ol
1629016-31-4
|
Methyl 1,6-dihydroxy-1,3-dihydrobenzo[c][1,2]oxaborole-7-carboxylate
1629142-31-9
|
N-(4-Bromo-5-methylthiazol-2-yl)acetamide
1934494-58-2
|
5-Oxotetrahydro-2H-pyran-2-carboxylic acid
1924362-21-9
|
7-isopropylbenzo[c][1,2]oxaborole-1,6(3H)-diol
1629140-47-1
|
